Researchers have found that alcohol exposure in early pregnancy can change gene function during embryonic development and consequently cause developmental disorders.
The ultrahigh-speed sequencer is especially suitable for targeted gene sequencing and small genome sequencing, delivering rapid and high-quality data output.
Researchers have revealed new ways in which nature encodes biological information in a DNA sequence.
With 2022 being the Year of the Tiger according to the Chinese zodiac, it is appropriate that research efforts over the past 12 months have shone a light on the Australian thylacine.
Exposure to certain environmental risk factors during embryonic development can cause changes to a key gene, leading to alterations in social behaviour in zebrafish and mice.
One of the 344 studied blood analytes had widespread shared genetic influences with COVID-19, causing an increased risk of severe COVID-19.
Researchers tracked down the gene when they studied two individuals — a man and his niece — with congenital malformations.
Genetic testing for cardiomyopathy in children and their first-degree relatives provides a precise clinical diagnosis that could guide treatment options.
The library preparation workflow was developed for researchers using OGT's SureSeq haematology and CytoSure NGS panels. By reducing the number of clean-up steps and QC requirements, library preparation can be completed in just 4.5 h.
Now anyone can produce high-quality, reproducible NGS libraries at just a touch of a button.
OGT, a Sysmex Group Company, has launched the SureSeq Myeloid Plus panel to detect aberrations in genes implicated in a variety of myeloid disorders.
Researchers found that men are biologically older than women, with the observed sex difference partially (but not entirely) explained by men's more frequent smoking and larger body size.
Illumina has launched the NovaSeq X Series (NovaSeq X and NovaSeq X Plus) of production-scale sequencers, designed to enable faster, more powerful and more sustainable sequencing for genome medicine applications.
Macugen was the first RNA biotherapeutic approved by the US FDA in 2004, but did you know this is a pegylated RNA-modified aptamer?
The technology can activate any gene — including those that have been silenced — allowing new drug targets and causes of drug resistance to be further explored.